ProMIS Neurosciences to Participate in Upcoming Conferences and Events in September
Globe Newswire•01/09/2026•08:00 ET
0
Whiz Insights
CAMBRIDGE, Mass, Sept. 01, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing antibody therapeutics and vaccines targeting toxic misfolded proteins in neurodegenerative diseases, today announced that it will participate in upcoming September 2026 conferences and key investor events, and will be available for one-on-one meetings.
September 9-11: Cantor Global Healthcare Conference Location: New York, NY Fireside Chat: Wednesday, September 9, 9:10-9:40 a.m. ET Participants: Pete Stavropoulos, Cantor analyst, and Neil Warma, ProMIS President & Chief Executive Officer Webcast link: Click Here
Get started
Create a free account to read the full story.